See more : Novo Nordisk A/S (NOVO-B.CO) Income Statement Analysis – Financial Results
Complete financial analysis of UGREEN GROUP LIMIT (301606.SZ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of UGREEN GROUP LIMIT, a leading company in the None industry within the None sector.
You may be interested
- DURATEK (8098.TWO) Income Statement Analysis – Financial Results
- BriaCell Therapeutics Corp. (BCTX) Income Statement Analysis – Financial Results
- Condor Hospitality Trust, Inc. (CDOR) Income Statement Analysis – Financial Results
- Banco do Brasil S.A. (BBAS3.SA) Income Statement Analysis – Financial Results
- Signal Hill Acquisition Corp. (SGHL) Income Statement Analysis – Financial Results
UGREEN GROUP LIMIT (301606.SZ)
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 4.80B | 3.83B | 3.44B | 2.73B | 2.04B |
| Cost of Revenue | 3.00B | 2.41B | 2.17B | 1.70B | 1.03B |
| Gross Profit | 1.81B | 1.41B | 1.26B | 1.02B | 1.01B |
| Gross Profit Ratio | 37.59% | 36.89% | 36.75% | 37.59% | 49.38% |
| Research & Development | 215.89M | 183.34M | 156.61M | 95.13M | 64.89M |
| General & Administrative | 41.46M | -151.68M | 37.80M | 25.49M | 0.00 |
| Selling & Marketing | 722.04M | 665.54M | 582.72M | 452.47M | 0.00 |
| SG&A | 763.51M | 859.46M | 738.65M | 559.60M | 674.46M |
| Other Expenses | 388.01M | -20.08M | -30.66M | -9.71M | -7.80M |
| Operating Expenses | 1.37B | 1.06B | 925.91M | 664.44M | 747.14M |
| Cost & Expenses | 4.36B | 3.48B | 3.10B | 2.37B | 1.78B |
| Interest Income | 9.69M | 7.55M | 1.13M | 349.40K | 155.49K |
| Interest Expense | 11.97M | 7.49M | 4.86M | 3.77M | 2.90K |
| Depreciation & Amortization | 51.92M | 46.70M | 30.95M | 4.55M | 3.43M |
| EBITDA | 509.48M | 434.14M | 377.97M | 364.95M | 265.13M |
| EBITDA Ratio | 10.61% | 10.33% | 10.71% | 13.39% | 12.92% |
| Operating Income | 437.73M | 348.41M | 337.31M | 360.40M | 260.21M |
| Operating Income Ratio | 9.11% | 9.11% | 9.81% | 13.22% | 12.75% |
| Total Other Income/Expenses | 7.85M | 3.57M | 2.72M | -1.21M | -254.90K |
| Income Before Tax | 445.58M | 376.73M | 345.92M | 359.20M | 262.64M |
| Income Before Tax Ratio | 9.28% | 9.85% | 10.06% | 13.18% | 12.87% |
| Income Tax Expense | 51.90M | 46.74M | 41.03M | 53.17M | 35.28M |
| Net Income | 387.52M | 327.43M | 296.60M | 297.99M | 225.41M |
| Net Income Ratio | 8.07% | 8.56% | 8.63% | 10.93% | 11.05% |
| EPS | 0.93 | 0.79 | 0.71 | 0.72 | 0.54 |
| EPS Diluted | 0.93 | 0.79 | 0.71 | 0.72 | 0.54 |
| Weighted Avg Shares Out | 414.91M | 414.91M | 414.91M | 414.91M | 414.91M |
| Weighted Avg Shares Out (Dil) | 414.91M | 414.91M | 414.91M | 414.91M | 414.91M |
No news found for: 301606.SZ
Source: https://incomestatements.info
Category: Stock Reports